NMR screening of low molecular weight inhibitors targeting the papain‐like protease ( PLPro ) of SARS ‐ CoV ‐2
FEBS Open Bio · 2025
DOI: 10.1002/2211-5463.70082 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2025. Verfasst von Dennis J Pyper und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-University Frankfurt/M, Germany. Hauptthemen laut MEDLINE: SARS-CoV-2, Coronavirus Papain-Like Proteases, Antiviral Agents, Protease Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Maryland, Deutsche Forschungsgemeinschaft, Jenny T. Sih Endowed Memorial Fellowship.
Abstract (Originalsprache)
The Papain‐like protease (PLPro) from SARS‐CoV‐2 plays an important role in the cleavage of the polyproteins Pp1a and Pp1ab as well as in the suppression of the immune response by deISG15ylation. Considerable effort is therefore devoted to developing low molecular weight inhibitors as starting points for antiviral drugs. Here, we present the results of an NMR screening study of PLPro for binding to the DSI‐poised fragment library containing 607 compounds. Based on saturation‐transfer difference (STD)‐ and WaterLOGSY‐NMR experiments, we identified 86 binding compounds. We prioritized five candidates for further in‐depth analysis. For three of those, we determined dissociation constants and two distinct binding sites on PLPro. These compounds could serve as a basis for future drug design studies in medicinal chemistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance (BMRZ), Goethe-University Frankfurt/M, Germany.
- Center for Biomolecular Structure and Organization, Department of Chemistry and Biochemistry, University of Maryland, College Park, MD, USA.
ORCID-Profile: Harald Schwalbe
Förderung
- University of Maryland
- Deutsche Forschungsgemeinschaft
- Jenny T. Sih Endowed Memorial Fellowship
- European Union's Horizon 2020 research and innovation program
- Hessisches Ministerium für Wissenschaft und Kunst
- Maryland Summer Scholarship
Zitieren
APA
Pyper, D. J., Sreeramulu, S., Lanham, B. T., Engle, E. M., Fushman, D., & Schwalbe, H. (2025). NMR screening of low molecular weight inhibitors targeting the papain‐like protease ( PLPro ) of SARS ‐ CoV ‐2. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70082
Vancouver
Pyper DJ, Sreeramulu S, Lanham BT, Engle EM, Fushman D, Schwalbe H. NMR screening of low molecular weight inhibitors targeting the papain‐like protease ( PLPro ) of SARS ‐ CoV ‐2. FEBS Open Bio. 2025. doi:10.1002/2211-5463.70082
BibTeX
@article{Pyper2025,
author = {Pyper, Dennis J and Sreeramulu, Sridhar and Lanham, Benjamin T and Engle, Elizabeth M and Fushman, David and Schwalbe, Harald},
title = {NMR screening of low molecular weight inhibitors targeting the papain‐like protease ( PLPro ) of SARS ‐ CoV ‐2},
journal = {FEBS Open Bio},
year = {2025},
doi = {10.1002/2211-5463.70082}
}
EUVIMED